Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.7100 (3.17%) ($12.1000 - $13.0700) on Wed. Aug. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.76% (three month average) | RSI | 46 | Latest Price | $12.7100(3.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.38% in a week (0% probabilities). VIXM(-31%) VXX(-26%) XLC(-10%) UNG(-9%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.38% (StdDev 6.76%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
1 - 5 Day Possible Target | $1.46(-88.51%) | Resistance Level | $13.51 | 5 Day Moving Average | $12.79(-0.63%) | 10 Day Moving Average | $13.1(-2.98%) | 20 Day Moving Average | $13.51(-5.92%) | To recent high | -18% | To recent low | 49.5% | Market Cap | $944m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |